Abstract:A series of new copper(II) complexes were prepared. They are [CuL1(NCS)] (1), [CuClL1]·CH3OH (2), [CuClL2]·CH3OH (3), [CuL3(NCS)]·CH3OH (4), [CuL4(NCS)]·0.4H2O (5), and [CuL5(bipy)] (6), where L1, L2, L3 and L4 are the deprotonated form of N′-(2-hydroxybenzylidene)-3-methylbenzohydrazide, 4-bromo-N′-(2-hydroxy-5-methoxybenzylidene)benzohydrazide, N′-(2-hydroxy-5-methoxybenzylidene)-3-methylbenzohydrazide and 2-chloro-N′-(2-hydroxy-5-methoxybenzylidene)benzohydrazide, respectively, L5 is the dianionic form of N′-(2-hydroxybenzylidene)-3-methylbenzohydrazide, and bipy is 2,2′-bipyridine. The complexes were characterized by infrared and UV–Vis spectra and single crystal X-ray diffraction. The Cu atoms in complexes 1, 2, 3, 4 and 5 are coordinated by the NOO donor set of the aroylhydrazone ligands, and one Cl or thiocyanate N atom, forming square planar coordination. The Cu atom in complex 6 is in a square pyramidal coordination, with the NOO donor set of L1, and one N atom of bipy defining the basal plane, and with the other N atom of bipy occupying the apical position. Complexes 1, 2, 3, 4 and 5 show effective urease inhibitory activities, with IC50 values of 5.14, 0.20, 4.06, 5.52 and 0.26μM, respectively. Complex 6 has very weak activity against urease, with IC50 value over 100μM. Molecular docking study of the complexes with the Helicobacter pylori urease was performed. The relationship between structures and urease inhibitory activities indicated that copper complexes with square planar coordination are better models for urease inhibition.

Transition Metal Complexes (m=cu, Ni and Mn) of Schiff-base Ligands: Syntheses, Crystal Structures, and Inhibitory Bioactivities Against Urease and Xanthine Oxidase

Synthesis, Crystal Structure and Urease Inhibitory Activities of Schiff Base Metal Complexes

Synthesis, Molecular Docking and Biological Evaluation of Schiff Base Transition Metal Complexes As Potential Urease Inhibitors

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

Synthesis, Structures and Urease Inhibition Studies of Copper(ii) and Nickel(ii) Complexes with Bidentate N,O-donor Schiff Base Ligands.

Synthesis, Crystal Structure, and Urease Inhibition Studies of Copper(Ii) and Cobalt(Iii) Complexes with Bi(2-Fluorobenzylaminoethyl)Amine

Synthesis, Characterization and Crystal Structures of Schiff Base Copper Complexes with Urease Inhibitory Activity

Urease inhibition studies of six Ni(II), Co(II) and Cu(II) complexes with two sexidentate N<sub>2</sub>O<sub>4</sub>-donor bis-Schiff base ligands: An experimental and DFT computational study

Synthesis, Structure, and Urease Inhibitory Activities of Three Binuclear Copper(ii) Complexes with Protocatechuic Acid Derivative

Synthesis and Biological Evaluation of Cu(Ii), Zn(Ii), and Ni(Ii) 3-(4-nitrophenyl)acrylic Acid Complexes with Diamines As Potential Urease Inhibitors

Schiff base transition metal complexes as novel inhibitors of xanthine oxidase.

Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

Synthesis, Crystal Structures, Molecular Docking and Urease Inhibitory Activity of Nickel(ii) Complexes with 3-Pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Synthesis, Crystal Structures, DFT Studies, Molecular Docking and Urease Inhibition Studies of Three Ni(II) Complexes with a Sexidentate N2O4-donor Bis-Schiff Base Ligand

Synthesis, Structure, Urease Inhibitory, and Cytotoxic Activities of Two Complexes with Protocatechuic Acid Derivative and Phenanthroline

Preparations, Characterization, and Biological Features of Mononuclear Cu(II) Complexes Based on Hydrazone Ligands.

Synthesis, Structures and Helicobacter Pylori Urease Inhibitory Activity of Copper(ii) Complexes with Tridentate Aroylhydrazone Ligands.

Synthesis, crystal structures and urease inhibition of nickel(II), copper(II), zinc(II) and molybdenum(VI) complexes derived from N,n'-bis(4-bromosalicylidene)-1,3-propanediamine

Syntheses, characterizations, crystal structures, antibacterial and SOD-like activities of nickel(II) and copper(II) complexes with 2-((Z)-(4-methoxyphenylimino)methyl)-4,6-dichlorophenol

Synthesis, Crystal Structures and Urease Inhibition of Copper(II) and Zinc(II) Complexes Derived from N,N’-Bis(4-bromosalicylidene)-1,3-propanediamine

New Method for the Synthesis of A Mononucleating Cyclic Peptide Ligand, Crystal Structures of Its Ni, Zn, Cu, and Co Complexes, and Their Inhibitory Bioactivity Against Urease